Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
Author(s) -
Roland Seiler,
H.A.D.M. Ashab,
Nicholas Erho,
Bas W.G. van Rhijn,
Brian Winters,
James W. Douglas,
Kim E. Van Kessel,
Elisabeth E. Fransen van de Putte,
Matthew Sommerlad,
Natalie Q. Wang,
Voleak Choeurng,
Ewan A. Gibb,
Beatrix Palmer-Aronsten,
Lucia L.C. Lam,
Christine Buerki,
Elai Davicioni,
Gottfrid Sjödahl,
Jordan Kardos,
Katherine A. Hoadley,
Seth P. Lerner,
David J. McConkey,
Woonyoung Choi,
William Y. Kim,
Bernhard Kiss,
George N. Thalmann,
Tilman Todenhöfer,
Simon J. Crabb,
Scott North,
Ellen C. Zwarthoff,
Joost L. Boormans,
Jonathan L. Wright,
Marc Dall’Era,
Michiel S. van der Heijden,
Peter C. Black
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/f95t-1q90
Subject(s) - bladder cancer , chemotherapy , neoadjuvant therapy , oncology , medicine , cancer , breast cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom